Jan 10, 2025 · While Johnson & Johnson has been recognized as the industry leader in deal-making, sustained success takes looking ahead to remain a desired Partner of Choice – and …

Johnson & Johnson has long been a partner of choice for the next generation of innovators. From major acquisitions, including Shockwave and V-Wave in MedTech and Ambrx, Proteologix, …

What reporting data are top pharma R&D and BD? What’s next for the university-industry ecosystem after COVID-19? What do R&D teams want from universities? Learn more about …

In this insightful session, you'll learn about the common pitfalls organizations face during change implementation and how to navigate them effectively. We'll delve into strategies that have …

We boldly pursue transformational licensing, acquisition, and collaboration opportunities that accelerate breakthrough innovation to prevent, treat and cure some of the world’s most …

In this exclusive webinar, the VP and Global Head of Search & Evaluation, explains how AbbVie chose to position itself as a partner of choice for biotechs.

Nov 13, 2023 · Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, …

Ajay Gautam joined Inpart to shares insights on how Johnson & Johnson has built its reputation as a partner of choice for biotechs and how out-licensors can elevate their outreach and get on...

In our 2023 Partnering 2030 survey, Johnson & Johnson was ranked first amongst top pharma companies for its overall partnering experience.

Johnson & Johnson has 25 partners, 15 are technology partners and 10 are channel partners. Sustainable Packaging Coalition is its largest partner.